Dihydroisotanshinone I inhibited the migration of these prostate cancer cells by interrupting the cross-talk between macrophages and prostate cancer cells through the repression of the CCL2–STAT3 axis [92]. This evidence concerns the gene CCL2 and Familial prostate cancer.